R.J. Bright-Thomas

University of Manchester

Papers

1

Total Citations

108

H-Index

1

About

Dr. R.J. Bright-Thomas is a leading respiratory researcher whose work has fundamentally reshaped our understanding of lung infections in cystic fibrosis (CF). Moving beyond traditional culture-based methods, their research pioneered the application of metagenomic sequencing to CF sputum, revealing the lung as a dynamic polymicrobial ecosystem. Their landmark 2015 study, cited over 100 times, demonstrated that severe lung disease is linked to a dramatic loss of microbial diversity and the rapid emergence of previously undetected pathogens. This work established a clinically viable microbiome surveillance protocol, enabling clinicians to track the entire microbial community in real time. By showing that standard microbiology was missing critical shifts in the lung ecosystem, Bright-Thomas provided the framework for a new, more comprehensive approach to managing CF infections. Their contributions have opened the door to personalized, microbiome-informed therapies, making them a pivotal figure in the transition from single-pathogen thinking to a holistic view of respiratory health.

Research Focus

Key Achievements

1
H-Index
1
Papers
108
Total Citations
108
Avg Citations/Paper
🏆 Most Cited Paper
Rapid Detection of Emerging Pathogens and Loss of Microbial Diversity Associated with Severe Lung Disease in Cystic Fibrosis
108 citations · 2015
📈 Most Prolific Year: 2015 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: University of Manchester

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago